Genetic Technologies Limited
(NASDAQ: GENE)
|
8:30 PM UTC, 07/26/24 | |||
---|---|---|---|---|
Last: $0.85 | Change: +0.07 | %Change: +8.52% | Volume: 68,761 |
Open: | $ 0.79 | Volume: | 68,761 | |
---|---|---|---|---|
High: | $ 0.88 | Yield(%) | 0.00 | |
Low: | $ 0.77 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 3.83M | |
EPS ($) | n/a | Shares Out: | 4.85M |
% Price Change (last 4 weeks): | -46.95 |
---|---|
% Price Change (last 13 weeks): | -63.99 |
% Price Change (last 26 weeks): | -61.33 |
% Price Change (last 52 weeks): | -80.85 |
% Price Change (year to date): | -67.08 |
Return on Equity (%): | -84.41 |
---|---|
Return on Assets (%): | -65.34 |
Return on Invested Capital (%): | -60.10 |
Gross Profit Margin (%): | -28.57 |
---|---|
Net Profit Margin (%): | -135.28 |
Operating Profit Margin (%): | -135.45 |
|
|
50-day Moving Average: | $1.57 |
---|---|
200-day Moving Average: | $2.44 |
Avg. Daily Vol. (last 50 days): | 93,917 |
Avg. Daily Vol. (last 200 days): | 44,012 |
52-wk high: | $4.65 |
52-wk low: | $0.75 |
Bid: | $0.85 |
Ask: | $0.88 |
Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. It operates through ,the EasyDNA, AffinityDNA, and GeneType/Corporate segments. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment deals with AffinityDNA branded test sales and expenses. The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.
|
Genetic Technologies Limited
60-66 Hanover Street Fitzroy VI 3065 Phone: 61.3.8412.7000 Fax: 61.3.8412.7040 http://www.genetype.com |
Earnings (1year) ($): | -28.65 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 48.28 |
Cash Flow ($): | -48.40 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 0.12 |
Price/Book (x): | 0.09 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 3.07 |
---|---|
Current Ratio (x): | 3.17 |
LT Debt/Equity (x): | 2.05 |
Total Debt/Equity (x): | 4.77 |